改良衰弱表型在中国老年人中的验证:用于医疗实践中的衰弱识别
本研究基于CHARLS队列1978名老年人及上海社区横断面研究972名老年人,开发了包含握力特定切点和5次坐立试验替代步速的中国改良衰弱表型(CMFP),并评估其信效度。CMFP与Fried衰弱表型(FFP)一致性良好,AUC分别为0.936和0.928,且能显著预测全因死亡、ADL/IADL失能、住院和抑郁等结局。
要点
- CMFP与FFP的Spearman相关系数在CHARLS为0.795,在上海研究中为0.676。
- CMFP预测效度优秀,AUC在两项研究中分别为0.936和0.928。
- 5次坐立试验可作为步速评估的可行替代,与2.5米步行测试显著相关。
核心结论
- CMFP是有效的衰弱识别工具,尤其对全因死亡、ADL/IADL失能、住院和抑郁等结局具有优秀预测能力。
研究设计与样本
- 纵向研究(CHARLS队列1978名老年人,年龄67.4±6.16岁)和横断面研究(上海社区972名老年人,年龄72.8±6.75岁)。
主要发现
- 5次坐立试验与2.5米步行测试显著相关,r在CHARLS为0.373、在上海研究为0.423。
- CMFP各要素与总分呈中至强相关,Cronbach's alpha在两组人群中分别为0.303和0.358。
- CMFP与FFP的Spearman's r和kappa值在CHARLS为0.795和0.663,在上海研究为0.676和0.537。
- CMFP预测结局的AUC在两项研究中分别为0.936和0.928。
- CMFP评估的衰弱显著预测未来全因死亡、ADL/IADL失能、住院和抑郁的发生。
关键数值与推荐
- CMFP包含握力特定切点和以5次坐立试验替代步速评估。
- CMFP与FFP的Spearman's r在CHARLS为0.795、在上海研究为0.676,kappa值分别为0.663和0.537。
- CMFP预测结局的AUC在CHARLS为0.936、在上海研究为0.928。
临床怎么用
- CMFP可系统整合到临床前实践中,用于识别衰弱个体,尤其适用于空间受限的环境。
- 5次坐立试验可作为评估行动迟缓的可行替代测试。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The study aimed to evaluate a simplified and practical frailty detection tool derived from the Fried frailty phenotype (FFP). This tool was developed to facilitate the identification of frail individuals in constrained settings, addressing the challenges posed by uncertain cutoffs of FFP indicators in prompt frailty assessment. DESIGN: A longitudinal study and a cross-sectional study. SETTINGS AND PARTICIPANTS: A total of 1978 older adults aged 67.4 ± 6.16 years from the China Health and Retirement Longitudinal Study (CHARLS), and 972 older adults aged 72.8 ± 6.75 years from a pilot cross-sectional study conducted in Shanghai communities. METHODS: Frailty was assessed according to the FFP criterion. A Chinese modified frailty phenotype (CMFP) was developed, incorporating specific cutoffs for grip strength and an alternative test for walk speed. The internal consistency reliability, the criterion, and predictive validity of the CMFP were evaluated. RESULTS: The 5-time chair stand test (5t-CST) was significantly associated with the 2.5-m walk test (r = 0.373 in the CHARLS and 0.423 in the pilot study). Each element of the CMFP showed moderate to strong correlations with the total CMFP score and showed Cronbach's alpha of 0.303 and 0.358 in both populations. The Spearman's r and kappa values between the CMFP and the FFP were 0.795 and 0.663 in the CHARLS, and 0.676 and 0.537 in the pilot study. The areas under the curve (AUC) were 0.936 and 0.928 in the 2 studies, respectively. In addition, frailty assessed by the CMFP significantly predicted future incidence of outcomes, including all-cause mortality, activities of daily living (ADL)/instrumental ADL disability, hospitalization, and depression. CONCLUSIONS AND IMPLICATIONS: The study demonstrated the CMFP as a valid tool, particularly highlighting its excellent predictive ability on outcomes. The 5t-CST may act as a viable alternative test for assessing slowness. The CMFP can be systematically integrated into preclinical practice to identify frail individuals, especially within constrained spaces.
引用
- Ye B, Li Y, Wang Y, et al. A Modified Frailty Phenotype Used for Identifying Frailty in Health Care Practice: Validation Among Chinese Older Adults. J Am Med Dir Assoc. 2024. PMID: 38750655. doi:10.1016/j.jamda.2024.105016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。